- Home
- DMN vs ENVB Comparison
DMN vs ENVB Comparison
Compare DMN & ENVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMN
- ENVB
- Stock Information
- Founded
- DMN 2020
- ENVB 1994
- Country
- DMN Canada
- ENVB United States
- Employees
- DMN N/A
- ENVB N/A
- Industry
- DMN
- ENVB Biotechnology: Pharmaceutical Preparations
- Sector
- DMN
- ENVB Health Care
- Exchange
- DMN NYSE
- ENVB Nasdaq
- Market Cap
- DMN 3.0M
- ENVB 3.2M
- IPO Year
- DMN N/A
- ENVB N/A
- Fundamental
- Price
- DMN $0.01
- ENVB $1.30
- Analyst Decision
- DMN
- ENVB Strong Buy
- Analyst Count
- DMN 0
- ENVB 1
- Target Price
- DMN N/A
- ENVB $10.00
- AVG Volume (30 Days)
- DMN 749.8M
- ENVB 55.8K
- Earning Date
- DMN 05-27-2025
- ENVB 05-14-2025
- Dividend Yield
- DMN N/A
- ENVB N/A
- EPS Growth
- DMN N/A
- ENVB N/A
- EPS
- DMN 0.09
- ENVB N/A
- Revenue
- DMN $49,523.00
- ENVB N/A
- Revenue This Year
- DMN N/A
- ENVB N/A
- Revenue Next Year
- DMN N/A
- ENVB N/A
- P/E Ratio
- DMN $0.08
- ENVB N/A
- Revenue Growth
- DMN N/A
- ENVB N/A
- 52 Week Low
- DMN $0.00
- ENVB $1.01
- 52 Week High
- DMN $4.95
- ENVB $222.75
- Technical
- Relative Strength Index (RSI)
- DMN N/A
- ENVB 37.06
- Support Level
- DMN N/A
- ENVB $1.20
- Resistance Level
- DMN N/A
- ENVB $1.49
- Average True Range (ATR)
- DMN 0.00
- ENVB 0.10
- MACD
- DMN 0.00
- ENVB 0.10
- Stochastic Oscillator
- DMN 0.00
- ENVB 34.84
About DMN DAMON INC
Damon Inc is a motorcycle manufacturing company that aims to transform the motorcycle industry by building a smart and technologically advanced motorcycle. Damon is developing technology and investing in capabilities to lead the industry in the transformation of the high-performance electric motorcycle market. It is introducing existing enthusiasts to high-performance electric products while bringing new riders to the motorcycle community with first-of-its-kind advances in zero-emissions motorcycle performance, safety, connectivity and AI.
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.